Protein c deficiency (acquired)D68.5

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

Acquired protein C deficiency; Protein C deficiency

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Acquired deficiency or lack of protein C.

ClassificationThis section has been translated automatically.

In addition to congenital protein C deficiencies, there are also a number of exogenously caused protein C deficiencies:

  • Coumarin therapy
  • Asparaginase therapy in the context of leukemia treatment
  • in liver diseases, e.g. Budd-Chiari syndrome or venooclusive syndrome (VOD)
  • for consumption coagulopathy
  • after operations following polytrauma
  • for progressive renal insufficiency
  • for vitamin K deficiency
  • in sepsis
  • post-infectious (cloinical) symptoms 10-14 days after the first infection infections (e.g. varicella)
  • with massive blood loss
  • for chronic inflammatory bowel disease.

The protein C concentration can be increased in:

EtiopathogenesisThis section has been translated automatically.

Together with a coenzyme, protein S, the protein C/protein S system is activated via the thrombin-thrombomodulin complex in a negative feedback reaction and inhibits the activated factors V and VIII (Va, VIIIa) by proteolytic cleavage. Thus, the protein C/protein S system plays a key role in the inhibition of hemostasis, because with this action it controls the activation of factor X to Xa and thus of prothrombin to thrombin.

LiteratureThis section has been translated automatically.

  1. HA Neumann (2014) The coagulation system. ABW-Wissenschaftsverlag GmbH Berlin S. 219f.

Authors

Last updated on: 29.10.2020